|
NCAPH expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65423230669148E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.30230048966951E-10 |
| Normal-vs-Stage2 |
1.10050000001749E-06 |
| Normal-vs-Stage3 |
6.65599997340394E-09 |
| Normal-vs-Stage4 |
1.73360000021994E-07 |
| Stage1-vs-Stage2 |
5.630200E-01 |
| Stage1-vs-Stage3 |
1.646480E-02 |
| Stage1-vs-Stage4 |
6.822500E-04 |
| Stage2-vs-Stage3 |
1.161830E-01 |
| Stage2-vs-Stage4 |
2.602000E-03 |
| Stage3-vs-Stage4 |
3.880300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17683640610267E-14 |
| Normal-vs-AfricanAmerican |
1.058840E-03 |
| Normal-vs-Asian |
1.488410E-01 |
| Caucasian-vs-AfricanAmerican |
3.633700E-02 |
| Caucasian-vs-Asian |
4.619800E-01 |
| AfricanAmerican-vs-Asian |
3.127000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.40474307133809E-13 |
| Normal-vs-Female |
7.06660285842986E-11 |
| Male-vs-Female |
1.697040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.578200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.17570397861755E-11 |
| Normal-vs-Age(61-80Yrs) |
4.16600087760344E-11 |
| Normal-vs-Age(81-100Yrs) |
1.699950E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.025000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.067000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.911900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.496200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.347500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.065500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.985600E-04 |
| Normal-vs-Grade 2 |
1.59260382659454E-11 |
| Normal-vs-Grade 3 |
1.73050462848323E-12 |
| Normal-vs-Grade 4 |
5.22280000025965E-07 |
| Grade 1-vs-Grade 2 |
7.028600E-01 |
| Grade 1-vs-Grade 3 |
1.846400E-02 |
| Grade 1-vs-Grade 4 |
3.248800E-04 |
| Grade 2-vs-Grade 3 |
3.756100E-03 |
| Grade 2-vs-Grade 4 |
4.047100E-04 |
| Grade 3-vs-Grade 4 |
4.515600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.05449998627694E-09 |
| Normal-vs-ccB subtype |
1.61129998232923E-10 |
| ccA subtype-vs-ccB subtype |
5.581200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.9110936711495E-12 |
| Normal-vs-N1 |
1.961560E-03 |
| N0-vs-N1 |
2.292300E-02 |
|
|
